Genetic Testing for Supravalvar Aortic Stenosis: What to Do When It Is Not Williams Syndrome

Overview

Journal J Am Heart Assoc

Specialty Cardiology & Vascular Diseases

Date 2024 Apr 9

PMID 38591341

Authors

Sara B Stephens

Tyler Novy

Gabrielle N Spurzem

Benjamin Jacob

Taylor Beecroft

Emily Soludczyk

Beth A Kozel

Justin Weigand

Shaine A Morris

Affiliations

Soon will be listed here.

Abstract

Background: We aimed to describe the frequency and yield of genetic testing in supravalvar aortic stenosis (SVAS) following negative evaluation for Williams-Beuren syndrome (WS).

Methods And Results: This retrospective cohort study included patients with SVAS at our institution who had a negative evaluation for WS from May 1991 to September 2021. SVAS was defined as (1) peak supravalvar velocity of ≥2 meters/second, (2) sinotubular junction or ascending aortic score <-2.0, or (3) sinotubular junction score <-1.5 with family history of SVAS. Patients with complex congenital heart disease, aortic valve disease as the primary condition, or only postoperative SVAS were excluded. Genetic testing and diagnoses were reported. Of 162 patients who were WS negative meeting inclusion criteria, 61 had genetic testing results available (38%). Chromosomal microarray had been performed in 44 of 61 and was nondiagnostic for non-WS causes of SVAS. Sequencing of 1 or more genes was performed in 47 of 61. Of these, 39 of 47 underwent sequencing, 20 of 39 (51%) of whom had a diagnostic variant. Other diagnoses made by gene sequencing were Noonan syndrome (3 , 1 , Alagille syndrome (3 ), neurofibromatosis (1 ), and homozygous familial hypercholesterolemia (1 ). Overall, sequencing was diagnostic in 29 of 47 (62%).

Conclusions: When WS is excluded, gene sequencing for SVAS is high yield, with the highest yield for the gene. Therefore, we recommend gene sequencing using a multigene panel or exome analysis. Hypercholesterolemia can also be considered in individuals bearing the stigmata of this disease.

References

Park S, Seo E, Yoo H, Kim Y . Novel mutations in the human elastin gene (ELN) causing isolated supravalvular aortic stenosis. Int J Mol Med. 2006; 18(2):329-32. View

Mitchell M, Goldberg S . Supravalvar aortic stenosis in infancy. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2011; 14(1):85-91. DOI: 10.1053/j.pcsu.2011.01.013. View

Danetz J, Donofrio M, Embrey R . Multiple left-sided cardiac lesions in one of Noonan's original patients. Cardiol Young. 1999; 9(6):610-2. DOI: 10.1017/s1047951100005679. View

Metcalfe K, Rucka A, Smoot L, Hofstadler G, Tuzler G, McKeown P . Elastin: mutational spectrum in supravalvular aortic stenosis. Eur J Hum Genet. 2001; 8(12):955-63. DOI: 10.1038/sj.ejhg.5200564. View

Ganesan V, Kirkham F . Noonan syndrome and moyamoya. Pediatr Neurol. 1997; 16(3):256-8. DOI: 10.1016/s0887-8994(97)89980-8. View

Min S, Kinnear C, DAlessandro L, Bouwmeester J, Yao R, Chiasson D . Genetic Diagnosis and the Severity of Cardiovascular Phenotype in Patients With Elastin Arteriopathy. Circ Genom Precis Med. 2020; 13(6):e002971. PMC: 7748044. DOI: 10.1161/CIRCGEN.120.002971. View

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5):405-24. PMC: 4544753. DOI: 10.1038/gim.2015.30. View

Latham G, Ross F, Eisses M, Richards M, Geiduschek J, Joffe D . Perioperative morbidity in children with elastin arteriopathy. Paediatr Anaesth. 2016; 26(9):926-35. DOI: 10.1111/pan.12967. View

Delio M, Pope K, Wang T, Samanich J, Haldeman-Englert C, Kaplan P . Spectrum of elastin sequence variants and cardiovascular phenotypes in 49 patients with Williams-Beuren syndrome. Am J Med Genet A. 2013; 161A(3):527-33. DOI: 10.1002/ajmg.a.35784. View

10.

Curran M, Atkinson D, Ewart A, Morris C, Leppert M, Keating M . The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis. Cell. 1993; 73(1):159-68. DOI: 10.1016/0092-8674(93)90168-p. View

11.

McElhinney D, Krantz I, Bason L, Piccoli D, Emerick K, Spinner N . Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome. Circulation. 2002; 106(20):2567-74. DOI: 10.1161/01.cir.0000037221.45902.69. View

12.

Zhang R, Xie J, Zhou J, Xu L, Pan Y, Qu Y . Supravalvular Aortic Stenosis and the Risk of Premature Death Among Patients With Homozygous Familial Hypercholesterolemia. Am J Cardiol. 2021; 145:58-63. DOI: 10.1016/j.amjcard.2020.12.080. View

13.

Musunuru K, Hershberger R, Day S, Klinedinst N, Landstrom A, Parikh V . Genetic Testing for Inherited Cardiovascular Diseases: A Scientific Statement From the American Heart Association. Circ Genom Precis Med. 2020; 13(4):e000067. DOI: 10.1161/HCG.0000000000000067. View

14.

Allanson J . Noonan syndrome. Am J Med Genet C Semin Med Genet. 2007; 145C(3):274-9. DOI: 10.1002/ajmg.c.30138. View

15.

Merla G, Brunetti-Pierri N, Micale L, Fusco C . Copy number variants at Williams-Beuren syndrome 7q11.23 region. Hum Genet. 2010; 128(1):3-26. DOI: 10.1007/s00439-010-0827-2. View

16.

Dave J, Chakraborty R, Ntokou A, Saito J, Saddouk F, Feng Z . JAGGED1/NOTCH3 activation promotes aortic hypermuscularization and stenosis in elastin deficiency. J Clin Invest. 2022; 132(5). PMC: 8884911. DOI: 10.1172/JCI142338. View

17.

Hazekamp M, Kappetein A, Schoof P, Ottenkamp J, Witsenburg M, Huysmans H . Brom's three-patch technique for repair of supravalvular aortic stenosis. J Thorac Cardiovasc Surg. 1999; 118(2):252-8. DOI: 10.1016/S0022-5223(99)70215-1. View

18.

Olsen M, Fahy C, Costi D, Kelly A, Burgoyne L . Anaesthesia-related haemodynamic complications in Williams syndrome patients: a review of one institution's experience. Anaesth Intensive Care. 2014; 42(5):619-24. DOI: 10.1177/0310057X1404200512. View

19.

Merla G, Brunetti-Pierri N, Piccolo P, Micale L, Loviglio M . Supravalvular aortic stenosis: elastin arteriopathy. Circ Cardiovasc Genet. 2012; 5(6):692-6. DOI: 10.1161/CIRCGENETICS.112.962860. View

20.

Pober B, Johnson M, Urban Z . Mechanisms and treatment of cardiovascular disease in Williams-Beuren syndrome. J Clin Invest. 2008; 118(5):1606-15. PMC: 2358987. DOI: 10.1172/JCI35309. View